Clinical Trials on Mediastinal Cancer in China

Total 7227 results

Fudan University

Recruiting

Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer

Advanced Breast Cancer | HR+/HER2- Breast Cancer

China
Shanghai Huihe Medical Technology Co., Ltd

Enrolling by invitation

Polyvinyl Alcohol Embolization Microspheres

Primary Liver Cancer

China
Fudan University

Recruiting

Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab

Metastatic Breast Cancer | HER2-positive Breast Cancer

China
Wuhan Union Hospital, China

Recruiting

Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment

Stomach Cancer | Lung Cancer | Artificial Intelligence | Colon Cancer | Cancer, Treatment-Related | Cancer Risk | Deep Learning | Lung; Node | Cancer Screening

China
Nanjing Medical University

Unknown

Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Cancer.

Cancer

China
RemeGen Co., Ltd.

Recruiting

A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor

Digestive Cancer

China
Sun Yat-sen University
Innovent Biologics (Suzhou) Co. Ltd.

Unknown

Sintilimab in the Treatment of Advanced and Refractory Pediatric Malignant Tumors

Pediatric Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics

Advanced Cancer

China
Sichuan J.Z. Bio-chemical Science and Technology...
Peking University Cancer Hospital & Institute

Completed

Phase I Studies of Chlorogenic Acid for Injection for Tolerance and Pharmacokinetic of Advanced Cancers

Advanced Cancer

China
Beijing Friendship Hospital
Beijing Health Promotion Association

Recruiting

Comparison Between Prepectoral and Subpectoral Breast Reconstruction (RESPECT)

Stage I Breast Cancer | Stage II Breast Cancer

China
Shanghai Pudong Hospital
Duke University

Recruiting

An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis

Metastatic Cancer | Advanced Cancer

China
Qi Zhou

Not yet recruiting

A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH ) (PORCH)

1. Relapsed Ovarian Cancer 2. Metastatic Ovarian Cancer 3. Endometrial Cancer 4. Cervical Cancer

China
Shandong Golden Brick Biotechnology Co., Ltd.

Unknown

Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer

Advanced Gastric Cancer | Gastroesophageal Cancer

China
Siemens Molecular Imaging
Fudan University

Completed

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Head and Neck Cancer | Lung Cancer | Liver Cancer

China
Peking University

Active, not recruiting

Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of Anti- PD-1

Gastrointestinal System Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Study of AL2846 on Tolerance and Pharmacokinetics

Advanced Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics

Advanced Cancer

China
Fudan University

Recruiting

Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer (NeoTPPF)

HER2-positive Breast Cancer | Estrogen Receptor-positive Breast Cancer

China
Peking Union Medical College Hospital

Recruiting

A Comparative Study of Mammography and Ultrasound for Breast Cancer Screening and Early Diagnosis (MUSD)

Breast Cancer Screening | Breast Cancer Diagnosis

China
Zhu Xu

Unknown

Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE

Advanced Adult Primary Liver Cancer

China
Shandong University
The Affiliated Hospital of Qingdao University; Qianfoshan Hospital; The Second...

Recruiting

Antineoplastic Drugs in Elderly Patients

Cancer

China
Central South University

Recruiting

Hepatotoxicity Related to Protein Kinase Inhibitors

Cancer

China
Tongji Hospital
Shanghai IASO Biotechnology Co., Ltd

Recruiting

Safety and Efficacy of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors

Cancer

China
Shenzhen Geno-Immune Medical Institute

Unknown

Immunotherapy Treating GI Cancer

Cancer

China
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

The Efficacy and Safety of Palonosetron in Preventing the Gastrointestinal Reactions Induced by 3-day Highly Emetogenic Chemotherapy

Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Study of TQB3824 in Subjects With Advanced Cancer

Advanced Cancer

China
Shanghai East Hospital

Unknown

Clinical Study of Granulocyte Infusion for Advanced Cancer

Advanced Cancer

China
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Unknown

Safety and Tolerability of SH-1028 in Patients With Advanced Solid Cancer

Advanced Solid Cancer

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Development of a Scale for Cancer Patients' Willingness to Voluntarily Participate in Drug Clinical Trials

Cancer

China
Shanghai Zhongshan Hospital
Guangzhou Burning Rock Dx Co., Ltd.

Recruiting

Pan-canceR Early DetectIon projeCT (PREDICT)

Cancer

China
Henan Cancer Hospital

Unknown

An Immunogenic Personal Neoantigen Vaccine for Cancer Treatment

Cancer

China
Fudan University

Unknown

Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Metastatic Triple Negative Breast Cancer

Metastatic Breast Cancer

China
Peking Union Medical College Hospital

Recruiting

Studies on the Impact of Taste-aware Intelligent Analysis of Oral Nutritional Supplements

Stroke | Cancer- and Cancer Treatment-Related Conditions

China
Jacobio Pharmaceuticals Co., Ltd.

Recruiting

A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China

Head and Neck Cancer | Esophageal Cancer | Non-small Cell Lung Cancer | Other Metastatic Solid Tumors

China
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

B002 in Patients With HER2-positive Breast Cancer (B002-101)

Metastatic Breast Cancer | Recurrent Breast Cancer

China
Alexander Chi

Not yet recruiting

Combining ICI With SBRT or HypoFrx-RT for ES NSCLC

Non-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | Non-small Cell Carcinoma | Non-small Cell Lung Cancer Stage II

China
Chinese PLA General Hospital
Tsinghua University

Unknown

Autologous Natural Killer T Cells Infusion for the Treatment of Cancer

Glioma | Breast Cancer | Pancreatic Cancer | Prostate Cancer | Colon Cancer | Hepatocellular Cancer | Squamous Cell Lung Cancer

China
Fudan University

Recruiting

Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer (BCTOP-T-M01)

Triple-Negative Breast Cancer

China
Fudan University

Recruiting

Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE) (CITRINE)

Triple-negative Breast Cancer

China
Ruijin Hospital

Recruiting

Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer (NeoPATH)

Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer

China
Fudan University

Active, not recruiting

A Trial of Camrelizumab in Combination With Nab-paclitaxel and Famitinib as a First Line Treatment in Patients With Unresectable Locally Advanced or Metastatic Immunomodulatory Triple Negative Breast Cancer(FUTURE-C-PLUS)

Triple-Negative Breast Cancer

China
Tianjin Medical University Cancer Institute and...

Unknown

Neoadjuvant Treatment of Early Triple-negative Breast Cancer With Chidamide and Chemotherapy

Triple-negative Breast Cancer

China
Fudan University

Recruiting

PD-1 Inhibitor and Nab-paclitaxel and Bevacizumab in CUP

Cancer of Unknown Primary

China
Innovent Biologics (Suzhou) Co. Ltd.

Completed

First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors

Cancer, Solid Tumor

China
Clifford Hospital, Guangzhou, China

Completed

Safety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung Cancer (VCONSCLC)

Carcinoma, Non-Small-Cell Lung | Stage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer

China
Junyan Zhao

Active, not recruiting

Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients

Stomach Cancer | Breast Cancer | Lung Cancer | Rectal Cancer | Colon Cancer | Liver Cancer

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer

Advanced Breast Cancer | Metastatic Breast Cancer

China
Wuhan Union Hospital, China

Recruiting

Blood Cell RNA-Based Cancer Detection (eRBCDet)

Neoplasms | Cancer

China
Shenzhen Geno-Immune Medical Institute

Recruiting

PSMA/CD70 Bi-specific CAR-T Cell Therapy

Cancer Disease

China
Lanxi Hospital of Traditional Chinese Medicine
Zhejiang Cancer Hospital; Zhejiang Chinese Medical University

Active, not recruiting

Multi-cancer Joint Screening and Early Diagnosis and Treatment Project Based on the Combination of Chinese Traditional and Western Medicine in Lanxi City

Cancer Screening

China

Clinical Trials on Mediastinal Cancer in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations